Biological Activities of Cyclic and Acyclic B-Type Laxaphycins in SH-SY5Y Human Neuroblastoma Cells.

Abstract

Laxaphycins are a family of non-ribosomal lipopeptides that have been isolated from several cyanobacteria. Some of these compounds have presented cytotoxic activities, but their mechanism of action is poorly understood. In this work, the already described laxaphycins B and B3, and acyclolaxaphycins B and B3 were isolated from the marine cyanobacteria Anabaena torulosa. Moreover, two new acyclic compounds, [des-(Ala4-Hle5)] acyclolaxaphycins B and B3, were purified from the herviborous gastropod Stylocheilus striatus, with this being the first description of biotransformed laxaphycins. The structure of these new compounds was elucidated, together with the absolute configuration of acyclolaxaphycins B and B3. The bioactivities of the six peptides were determined in SH-SY5Y human neuroblastoma cells. Laxaphycins B and B3 were cytotoxic (IC50: 1.8 and 0.8 µM, respectively) through the induction of apoptosis. In comparison, acyclic laxaphycins did not show cytotoxicity but affected mitochondrial functioning, so their effect on autophagy-related protein expression was analyzed, finding that acyclic peptides affected this process by increasing AMPK phosphorylation and inhibiting mTOR. This work confirms the pro-apoptotic properties of cyclic laxaphycins B and is the first report indicating the effects on autophagy of their acyclic analogs. Moreover, gastropod-derived compounds presented ring opening and amino-acids deletion, a biotransformation that had not been previously described.

• Authors: Rebeca Alvariño, Eva Alonso, Louis Bornancin, Isabelle Bonnard, Nicolas Inguimbert, Bernard Banaigs, Luis M Botana
• Journal: Marine drugs (Mar Drugs) Vol. 18 Issue 7 (Jul 15 2020) ISSN: 1660-3397 [Electronic] Switzerland
• PMID: 32679743 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Antineoplastic Agents
• Laxaphycin B
• Peptides, Cyclic
• laxaphycin B3
• MTOR protein, human
• TOR Serine-Threonine Kinases
• AMP-Activated Protein Kinases

Topics

• AMP-Activated Protein Kinases (metabolism)
• Antineoplastic Agents (chemistry, pharmacology)
• Apoptosis (drug effects)
• Autophagy (drug effects)
• Cell Line, Tumor
• Dose-Response Relationship, Drug
• Humans
• Inhibitory Concentration 50
• Mitochondria (drug effects, metabolism, pathology)
• Neuroblastoma (drug therapy, metabolism, pathology)
• Peptides, Cyclic (chemistry, pharmacology)
• Phosphorylation
• Protein Conformation
• Structure-Activity Relationship
• TOR Serine-Threonine Kinases (metabolism)